Literature DB >> 20558531

The brief negative symptom scale: psychometric properties.

Brian Kirkpatrick1, Gregory P Strauss, Linh Nguyen, Bernard A Fischer, David G Daniel, Angel Cienfuegos, Stephen R Marder.   

Abstract

The participants in the NIMH-MATRICS Consensus Development Conference on Negative Symptoms recommended that an instrument be developed that measured blunted affect, alogia, asociality, anhedonia, and avolition. The Brief Negative Symptom Scale (BNSS) is a 13-item instrument designed for clinical trials and other studies that measures these 5 domains. The interrater, test-retest, and internal consistency of the instrument were strong, with respective intraclass correlation coefficients of 0.93 for the BNSS total score and values of 0.89-0.95 for individual subscales. Comparisons with positive symptoms and other negative symptom instruments supported the discriminant and concurrent validity of the instrument.

Entities:  

Mesh:

Year:  2010        PMID: 20558531      PMCID: PMC3044634          DOI: 10.1093/schbul/sbq059

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  30 in total

Review 1.  The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations.

Authors:  N C Andreasen
Journal:  Br J Psychiatry Suppl       Date:  1989-11

2.  The positive and negative syndrome scale (PANSS) for schizophrenia.

Authors:  S R Kay; A Fiszbein; L A Opler
Journal:  Schizophr Bull       Date:  1987       Impact factor: 9.306

3.  Factor structure of the negative symptom assessment.

Authors:  B N Axelrod; R S Goldman; J L Woodard; L D alphs
Journal:  Psychiatry Res       Date:  1994-05       Impact factor: 3.222

4.  The Schedule for the Deficit syndrome: an instrument for research in schizophrenia.

Authors:  B Kirkpatrick; R W Buchanan; P D McKenney; L D Alphs; W T Carpenter
Journal:  Psychiatry Res       Date:  1989-11       Impact factor: 3.222

5.  The diagnosis and understanding of schizophrenia. Part III. Speculations on the processes that underlie schizophrenic symptoms and signs.

Authors:  J S Strauss; W T Carpenter; J J Bartko
Journal:  Schizophr Bull       Date:  1974       Impact factor: 9.306

6.  Summer birth and deficit schizophrenia: a pooled analysis from 6 countries.

Authors:  Erick Messias; Brian Kirkpatrick; Evelyn Bromet; David Ross; Robert W Buchanan; William T Carpenter; Cenk Tek; Kenneth S Kendler; Dermot Walsh; Sonia Dollfus
Journal:  Arch Gen Psychiatry       Date:  2004-10

7.  The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse.

Authors:  B Kirkpatrick; X F Amador; M Flaum; S A Yale; J M Gorman; W T Carpenter; M Tohen; T McGlashan
Journal:  Schizophr Res       Date:  1996-05       Impact factor: 4.939

8.  The deficit syndrome in the DSM-IV Field Trial. Part II. Depressive episodes and persecutory beliefs.

Authors:  B Kirkpatrick; X F Amador; S A Yale; J R Bustillo; R W Buchanan; M Tohen
Journal:  Schizophr Res       Date:  1996-05       Impact factor: 4.939

9.  Case identification and stability of the deficit syndrome of schizophrenia.

Authors:  B Kirkpatrick; R W Buchanan; A Breier; W T Carpenter
Journal:  Psychiatry Res       Date:  1993-04       Impact factor: 3.222

10.  Validation of the 16-item Negative Symptom Assessment.

Authors:  B N Axelrod; R S Goldman; L D Alphs
Journal:  J Psychiatr Res       Date:  1993 Jul-Sep       Impact factor: 4.791

View more
  228 in total

Review 1.  A new perspective on anhedonia in schizophrenia.

Authors:  Gregory P Strauss; James M Gold
Journal:  Am J Psychiatry       Date:  2012-04       Impact factor: 18.112

Review 2.  Motivational Deficits in Schizophrenia and the Representation of Expected Value.

Authors:  James A Waltz; James M Gold
Journal:  Curr Top Behav Neurosci       Date:  2016

3.  Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.

Authors:  Sonia Dollfus; Cyril Mach; Rémy Morello
Journal:  Schizophr Bull       Date:  2015-11-12       Impact factor: 9.306

4.  Conceptualization and treatment of negative symptoms in schizophrenia.

Authors:  Sonali Sarkar; Kiley Hillner; Dawn I Velligan
Journal:  World J Psychiatry       Date:  2015-12-22

5.  New Standards for Negative Symptom Assessment.

Authors:  William T Carpenter; Jack J Blanchard; Brian Kirkpatrick
Journal:  Schizophr Bull       Date:  2015-11-28       Impact factor: 9.306

Review 6.  A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.

Authors:  Gregory P Strauss; Andrea Pelletier-Baldelli; Katherine Frost Visser; Elaine F Walker; Vijay A Mittal
Journal:  Schizophr Res       Date:  2020-06-07       Impact factor: 4.939

7.  Network Analysis Reveals Which Negative Symptom Domains Are Most Central in Schizophrenia vs Bipolar Disorder.

Authors:  Gregory Paul Strauss; Farnaz Zamani Esfahlani; Brian Kirkpatrick; Daniel N Allen; James M Gold; Katherine Frost Visser; Hiroki Sayama
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

8.  Salivary kynurenic acid response to psychological stress: inverse relationship to cortical glutamate in schizophrenia.

Authors:  Joshua Chiappelli; Laura M Rowland; Francesca M Notarangelo; S Andrea Wijtenburg; Marian A R Thomas; Ana Pocivavsek; Aaron Jones; Krista Wisner; Peter Kochunov; Robert Schwarcz; L Elliot Hong
Journal:  Neuropsychopharmacology       Date:  2018-04-18       Impact factor: 7.853

Review 9.  A meta-analytic review of self-reported, clinician-rated, and performance-based motivation measures in schizophrenia: Are we measuring the same "stuff"?

Authors:  Lauren Luther; Ruth L Firmin; Paul H Lysaker; Kyle S Minor; Michelle P Salyers
Journal:  Clin Psychol Rev       Date:  2018-04-07

10.  Emotion regulation abnormalities in schizophrenia: Directed attention strategies fail to decrease the neurophysiological response to unpleasant stimuli.

Authors:  Gregory P Strauss; Emily S Kappenman; Adam J Culbreth; Lauren T Catalano; Kathryn L Ossenfort; Bern G Lee; James M Gold
Journal:  J Abnorm Psychol       Date:  2014-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.